Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease

Neuroscience Letters

Volumn 462, Issue 1, 2009, Pages 89-93

  Solomon, Alina ^a,b   Leoni, Valerio ^b,c   Kivipelto, Miia ^a,b   Besga, Ariadna ^d   Öksengård, Anne Rita ^b   Julin, Per ^b   Svensson, Leif ^e   Wahlund, Lars Olof ^b   Andreasen, Niels ^e   Winblad, Bengt ^b   Soininen, Hilkka ^a   Björkhem, Ingemar ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cholesterol; Oxysterols

Indexed keywords

24 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; APOLIPOPROTEIN E; CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANOSTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BLOOD ANALYSIS; BRAIN METABOLISM; BRAIN SIZE; CHOLESTEROL METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; GRAY MATTER; HUMAN; HYPERCHOLESTEROLEMIA; ISOTOPE DILUTION ASSAY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SWEDEN; UNIVERSITY HOSPITAL; WHITE MATTER;

AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; HYDROXYCHOLESTEROLS; LANOSTEROL; MALE; MIDDLE AGED; ORGAN SIZE; SEX FACTORS;

EID: 67650432608     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.073     Document Type: Article

References (30)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Andersson, C., 2007. Predictors of cognitive decline in memory clinic patients. Doctoral thesis. Karolinska Institutet, Stockholm, Sweden. http://diss.kib.ki.se/2007/978-91-7357-232-3/thesis.pdf.
3. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260 6 (2006) 493-508
4. Bodovitz S., and Klein W.L. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271 (1996) 4436-4440
5. Bogdanovic N., Bretillon L., Lund E.G., Diczfalusy U., Lannfelt L., Winblad B., Russell D.W., and Björkhem I. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314 (2001) 45-48
6. Brandtberg T. Introduction to Fuzzy Sets-With Application to Image Processing and Pattern Recognition (1999), Centre for Image Analysis, Uppsala University
7. Brown J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 (2004) 34674-34681
8. den Heijer T., Hofman A., Koudstaal P.J., and Breteler M.M. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann. Neurol. 57 5 (2005) 779-780
9. Höppner F., Klawonn F., Kruse R., and Runkler T. Fuzzy Cluster Analysis: Methods for Classification, Data Analysis and Image Recognition (2000), Wiley
10. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Iivonen S., Mannermaa A., Tuomilehto J., Nissinen A., and Soininen H. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann. Intern. Med. 137 (2002) 149-155
11. Kivipelto M., and Solomon A. Cholesterol as a risk factor for Alzheimer's disease-epidemiological evidence. Acta Neurol. Scand. Suppl. 185 (2006) 50-57
12. Koschack J., Lütjohann D., Schmidt-Samoa C., and Irle E. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. Neurobiol Aging 30 6 (2009) 898-902
13. Koudinov A.R., and Koudinova N.V. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 15 (2001) 1858-1860
14. Leoni, V., 2005. On the possible use of oxysterols for the diagnosis and evaluation of patients with neurological and neurodegenerative diseases. Doctoral thesis. Karolinska Institutet, Stockholm, Sweden. http://diss.kib.ki.se/2005/91-7140-255-1/thesis.pdf.
15. Leoni V., Mariotti C., Tabrizi S.J., Valenza M., Wild E.J., Henley S.M., Hobbs N.Z., Mandelli M.L., Grisoli M., Björkhem I., Cattaneo E., and Di Donato S. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain 131 Pt 11 (2008) 2851-2859
16. Leoni V., Masterman T., Mousavi F.S., Wretlind B., Wahlund L.O., Diczfalusy U., Hillert J., and Björkhem I. Diagnostic use of cerebral and extracerebral oxysterols. Clin. Chem. Lab. Med. 42 2 (2004) 186-191
17. Lesser G., Kandiah K., Libow L.S., Likourezos A., Breuer B., Marin D., Mohs R., Haroutunian V., and Neufeld R. Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12 (2001) 138-145
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
19. Mielke M.M., Zandi P.P., Sjogren M., Gustafson D., Ostling S., Steen B., and Skoog I. High total cholesterol levels in late-life associated with a reduced risk of dementia. Neurology 64 (2005) 1689-1695
20. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., and Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17 1 (1998) 14-20
21. Reitz C., Tang M.X., Luchsinger J., and Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch. Neurol. 61 (2004) 705-714
22. Rockwood K. Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol. Scand. Suppl. 185 (2006) 71-77
23. Solomon A., Kåreholt I., Ngandu T., Winblad B., Nissinen A., Tuomilehto J., Soininen H., and Kivipelto M. Serum cholesterol changes after midlife and late-life cognition: 21-year follow-up study. Neurology 68 (2007) 751-756
24. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Browne P., Wasser D., Johnson-Traver S., Lochhead J., and Ziolwolski C. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol. 62 5 (2005) 753-757
25. Stewart R., White L.R., Xue Q.L., and Launer L.J. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 64 1 (2007) 103-107
26. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1977-1981
27. Suckling J., Sigmundsson T., Greenwood K., and Bullmore E.T. A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. Magn. Reson. Imaging 17 7 (1999) 1065-1076
28. Teunissen C.E., De Vente J., von Bergmann K., Bosma H., van Boxtel M.P., De Bruijn C., Jolles J., Steinbusch H.W., and Lütjohann D. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol. Aging 24 1 (2003) 147-155
29. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Bäckman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., and Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J. Intern. Med. 256 (2004) 240-246
30. Wolf H., Hensel A., Arendt T., Kivipelto M., Winblad B., and Gertz H.-J. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann. Neurol. 56 (2004) 745-749